Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 23.91 | N/A |
| PEG Ratio (TTM) | -0.93 | N/A |
| P/S Ratio (TTM) | 0.70 | N/A |
| P/B Ratio (TTM) | 1.66 | N/A |
| P/FCF Ratio (TTM) | 6.40 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.45 | N/A |
| Price to 5YR AVG FCF Ratio | 12.22 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.09% | N/A |
| ROE (TTM) | 7.07% | N/A |
| Net Profit Margin (TTM) | 3.37% | N/A |
| ROIC 5YR AVG | 10.04% | N/A |
Growth (65%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2,791.07% | 21.53% | 3.31% |
| Revenue | 1.08% | 12.24% | 6.51% |
| Net Income | 3,529.13% | 18.69% | 4.92% |
| Cash Flow | 289.37% | -29.91% | 227.04% |
Health (54%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.66 | N/A |
| Quick Ratio (TTM) | 2.19 | N/A |
| D/E Ratio (TTM) | 0.91 | N/A |
| Interest Coverage (TTM) | 3.22 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.65 | N/A |
| LTL to 5YR AVG FCF | 7.39 | N/A |
| Shares Outstanding Growth 5YR AVG | 3.41% | N/A |